4-iodotamoxifen aziridine, a new affinity labeling agent for the rapid detection of estrogen receptor isoforms

Journal of Steroid Biochemistry and Molecular Biology

Volumn 67, Issue 2, 1998, Pages 95-104

  Maaroufi, Younes ^a   Quivy, Jacques ^a   Trivedi, Sunil ^a   Gilot, Nathalie ^a   Leclercq, Guy ^a  

^a JULES BORDET INSTITUTE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; IODINE 125; RECEPTOR SUBTYPE; TAMOXIFEN AZIRIDINE;

ARTICLE; BINDING COMPETITION; BREAST CANCER; CONTROLLED STUDY; DIAGNOSTIC VALUE; DRUG RECEPTOR BINDING; HUMAN; HUMAN CELL; ISOTOPE LABELING; POLYACRYLAMIDE GEL ELECTROPHORESIS;

AFFINITY LABELS; ANIMALS; FEMALE; HUMANS; ORGAN SPECIFICITY; PROTEIN ISOFORMS; RATS; RECEPTORS, ESTROGEN; TAMOXIFEN;

EID: 0032191759     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(98)00102-2     Document Type: Article

References (26)

1. Leclercq G. Technical pitfalls, methodological improvements and quality controls of steroid hormone receptor assays. Eur. J. Cancer. 23:1987;453-458.
2. Kute T. E., Heidemann P., Wittliff J. L. Molecular heterogeneity of cytoplasmic forms of oestrogen receptors from human breast tumours. Cancer. 38:1978;4307-4313.
3. Murphy L. C., Dotzlaw H., Leygue E., Douglas D., Coutts A., Watson P. H. Estrogen receptor variants and mutations. J. Steroid Biochem. Mol. Biol. 62:1997;363-372.
4. 3H ]tamoxifen aziridine J. Biol. Chem. 258:1983;3487-3497.
5. Elliston J. F., Katzenellenbogen B. S. Comparative analysis of estrogen receptors covalently labeled with an estrogen and an antiestrogen in several estrogen target cells as studied by limited proteolysis. J. Steroid Biochem. 29:1988;559-569.
6. Piccart M., Muquardt C., Bosman C., Pirotte P., Veenstra S., Grillo F., Leclercq G. Comparison between tritiated estradiol and tamoxifen aziridine for measuring estrogen receptors in human breast cancer cytosols. J. Natl. Cancer Inst. 83:1991;1553-1559.
7. Monsma F. J., Katzenellenbogen B. S., Miller M. A., Ziegler Y. S., Katzenellenbogen J. A. Characterization of the estrogen receptor and its dynamics in MCF-7 human breast cancer cells using a covalently attaching antiestrogen. Endocrinology. 115:1984;143-153.
8. Trivedi S., Piccart M., Muquardt C., Gilot N., Hadiy S., Patel D., Leclercq G. Tamoxifen aziridine labeling of the estrogen receptor: potential utility in detecting biologically aggressive breast tumors. Breast Cancer Res. Treat. 40:1996;231-241.
9. 125I ]iododesethyl tamoxifen aziridine: synthesis and covalent labeling of the estrogen receptor with an iodine-labeled affinity label Steroids. 48:1986;287-313.
10. 125I -iodotamoxifen Int. J. Appl. Rad. Isot. 32:1981;171-173.
11. McCague R., Potter G. A. Synthesis of 4-stannylated tamoxifen analogues: useful precursors to radiolabelled idoxifene and aziridinyl 4-iodotamoxifen. J. Labeled Compounds Radiopharm. 34:1994;297-302.
12. Wooge C. H., Nilsson G. M., Heierson A., McDonnell D. P., Katzenellenbogen B. S. Structural requirements for high affinity ligand binding by estrogen receptors: a comparative analysis of truncated and full length estrogen receptors expressed in bacteria, yeast, and mammalian cells. Mol. Endocr. 6:1992;861-869.
13. Leclercq G., Legros N., Piccart M. J. Accumulation of a nonbinding form of estrogen receptor in MCF-7 cells under hydroxytamoxifen treatment. J. Steroid Biochem. Molec. Endocr. 41:1992;545-552.
14. Quivy J., Leclercq G., Deblaton M., Henrot P., Velings N., Norberg B., Evrard G., Zeicher M. Synthesis, structure and biological properties of Z-17α-(2-iodovinyl)-11β-chloromethyl estradiol-17β, a high affinity ligand for the characterization of estrogen receptor-positive tumors. J. Steroid Biochem. Molec. Biol. 59:1996;103-117.
15. Kushner P. J., Hort E., Shine J., Baxter J. D., Greene G. L. Construction of cell lines that express high levels of the human estrogen receptor and are killed by estrogens. Mol. Endocr. 10:1990;1465-1473.
16. Harlow K. W., Smith D. N., Katzenellenbogen J. A., Greene G. L., Katzenellenbogen B. S. Identification of cysteine 530 as the covalent attachment site of an affinity-labeling estrogen (ketonenestrol aziridine) and antiestrogen (tamoxifen aziridine) in the human estrogen receptor. J. Biol. Chem. 264:1989;17476-17485.
17. Horigome T. F., Ogata T. S., Golding F., Korach K. S. Estradiol-stimulated proteolytic cleavage of the estrogen receptor in mouse uterus. Endocrinology. 123:1988;2540-2548.
18. Maaroufi Y., Trivedi S., Leclercq G. Major molecular weight heterogeneity of estrogen receptor from breast cancer is not related to the neoplasia. Cancer Biochem. Biophys. 15:1995;67-78.
19. Giambiagi N., Pasqualini J. R. Interaction of three monoclonal antibodies with the nonactivated and activated forms of the estrogen receptor. Endocrinology. 126:1990;1403-1409.
20. Echeverria O. M., Maciel A. G., Traish A. M., Wotiz H. H., Ubaldo E., Vazquez-Nin G. H. Immuno-electron microscopic localization of estradiol receptor in cells of male and female reproductive and nonreproductive organs. Biol. Cell. 81:1994;257-265.
21. O'Malley B. W., Connelly O. M. Orphan receptors: in search of a unifying hypothesis for activation. Mol. Endocrinol. 6:1992;1359-1361.
22. Castles C. G., Fuqua S. A. W., Klotz D. M., Hill S. M. Expression of a constitutively active estrogen receptor variant in the estrogen receptor-negative BT 20 human breast cancer cell line. Cancer Res. 53:1993;5934-5939.
23. Borkowsky A., Gyling M., Muquardt C., Body J. J., Leclercq G. A subpopulation of immunoglobulin G in man selectively interacts in the hormone-binding sites of estrogen receptors. J. Clin. Endocrinol. Metab. 64:1987;356-363.
24. 125I ]methoxy iodovinyl estradiol in ovarian carcinomas J. Clin. Endocrinol. Metab. 61:1985;412-417.
25. Safa A. R., Roberts S., Agresti M., Fine R. L. Tamoxifen aziridine, a novel affinity probe for P-glucoprotein in multidrug resistant cells. Biochem. Biophys. Res. Comm. 202:1994;606-612.
26. 2+-dependent binding of tamoxifen to calmodulin isolated from bovine brain. Cancer Res. 50:1990;2753-2758.